AU2003295500A8 - Nuclear receptor-based diagnostic, therapeutic, and screening methods - Google Patents

Nuclear receptor-based diagnostic, therapeutic, and screening methods

Info

Publication number
AU2003295500A8
AU2003295500A8 AU2003295500A AU2003295500A AU2003295500A8 AU 2003295500 A8 AU2003295500 A8 AU 2003295500A8 AU 2003295500 A AU2003295500 A AU 2003295500A AU 2003295500 A AU2003295500 A AU 2003295500A AU 2003295500 A8 AU2003295500 A8 AU 2003295500A8
Authority
AU
Australia
Prior art keywords
therapeutic
screening methods
nuclear receptor
based diagnostic
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003295500A
Other versions
AU2003295500A1 (en
Inventor
Alexander Gracerov
Maria N Pavlova
Fusheng Li
George A Gaitanaris
John Hohmann
Linda Madisen
Demetri Vassilatis
Kellie L Mcilwain
Hongkui Zeng
John E Bergmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nura Inc
Original Assignee
Nura Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nura Inc filed Critical Nura Inc
Publication of AU2003295500A8 publication Critical patent/AU2003295500A8/en
Publication of AU2003295500A1 publication Critical patent/AU2003295500A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
AU2003295500A 2002-11-14 2003-11-12 Nuclear receptor-based diagnostic, therapeutic, and screening methods Abandoned AU2003295500A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42630502P 2002-11-14 2002-11-14
US60/426,305 2002-11-14
PCT/US2003/036229 WO2004045369A2 (en) 2002-11-14 2003-11-12 Nuclear receptor-based diagnostic, therapeutic, and screening methods

Publications (2)

Publication Number Publication Date
AU2003295500A8 true AU2003295500A8 (en) 2004-06-15
AU2003295500A1 AU2003295500A1 (en) 2004-06-15

Family

ID=32326328

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003295500A Abandoned AU2003295500A1 (en) 2002-11-14 2003-11-12 Nuclear receptor-based diagnostic, therapeutic, and screening methods

Country Status (2)

Country Link
AU (1) AU2003295500A1 (en)
WO (1) WO2004045369A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005075990A2 (en) * 2004-02-07 2005-08-18 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a2 (nr4a2)
WO2005075983A2 (en) * 2004-02-07 2005-08-18 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a3 (nr4a3)
WO2005085865A2 (en) * 2004-03-09 2005-09-15 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with thyroid hormone receptor beta (thrb)
WO2006005460A2 (en) * 2004-07-15 2006-01-19 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 2, group e, member 1 (nr2e1)
US9484123B2 (en) 2011-09-16 2016-11-01 Prc-Desoto International, Inc. Conductive sealant compositions
US10865446B2 (en) 2012-11-02 2020-12-15 The Johns Hopkins University DNA methylation biomarkers of post-partum depression risk
WO2014134627A1 (en) * 2013-03-01 2014-09-04 The Schepens Eye Research Institute, Inc. Methods for modulating development and function of photoreceptors cells
RU2716479C1 (en) * 2018-09-13 2020-03-11 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" Method for prediction of response to cardiac resynchronising therapy in patients with chronic heart failure
RU2747679C1 (en) * 2020-07-09 2021-05-12 федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии" Министерства здравоохранения Российской Федерации Method for predicting clinical course of highly differentiated neuroendocrine pancreatic tumors
CN112725438B (en) * 2021-02-05 2023-08-22 深圳市宝安区妇幼保健院 Endometrial polyp methylation marker combination, detection kit and application
CN116539902A (en) * 2023-07-05 2023-08-04 中国医学科学院北京协和医院 Application of differential lipid molecules as lipid markers and kit
CN116539901A (en) * 2023-07-06 2023-08-04 中国医学科学院北京协和医院 Application of differential metabolite as diagnostic marker and kit

Also Published As

Publication number Publication date
WO2004045369A3 (en) 2007-03-01
WO2004045369A2 (en) 2004-06-03
AU2003295500A1 (en) 2004-06-15

Similar Documents

Publication Publication Date Title
EP1588142A4 (en) Methods for diagnosing rcc and other solid tumors
EP1671584A4 (en) Lancing unit and lancing apparatus
AU2003203029A8 (en) Improved health-related devices and methods
AU2003240959A8 (en) Microarray detector and methods
AU2003261073A8 (en) Combined diagnostic and therapeutic ultrasound system
EP1595147A4 (en) Analysis system and procedure
EP1613214A4 (en) Respiratory monitoring, diagnostic and therapeutic system
EP1482327A4 (en) X-ray detector and method for producing x-ray detector
ZA200801829B (en) Novel enhanced processes for drug testing and screening using human tissue
EP1529487A4 (en) Electrocardiogram analysis device and method thereof
EP1572741A4 (en) Therapeutic and diagnostic agents
EP1573045A4 (en) Heart failure gene determination and therapeutic screening
GB2394052B (en) Walkaway tomographic monitoring
AU2003295500A8 (en) Nuclear receptor-based diagnostic, therapeutic, and screening methods
AU2003268032A8 (en) Composition and methods for treatment and screening
IL153183A0 (en) Agents for imaging and diagnostic methods using them
AU2003224956A8 (en) Reference structures and reference structure enhanced tomography
AU2003255544A8 (en) Tumor specific oligosaccharide epitopes and use thereof
AU2003274588A8 (en) Diagnostic x-ray system
EP1539957A4 (en) Novel diagnostic and therapeutic methods and reagents therefor
GB0212581D0 (en) Medical analysis device
EP1438431A4 (en) Methods for diagnosing and treating heart disease
GB0200757D0 (en) Diagnostic methods
AU2003242957A8 (en) Diagnostic microspheres
EP1408808A4 (en) Methods for diagnosing and treating heart disease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase